You can get semaglutide in the United States through three primary channels: a retail or mail-order pharmacy filling a prescription for Ozempic, Rybelsus, or Wegovy; a telehealth service such as Hims, Ro, Sequence, or Noom that prescribes and ships brand-name medication; or, in narrow patient-specific cases, a compounding pharmacy. All routes require a valid US prescription from a licensed clinician, and the legal landscape for compounded semaglutide has tightened sharply since the FDA declared the shortage resolved.
What Semaglutide Is and Who Can Prescribe It
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist developed by Novo Nordisk. It is FDA-approved in three brand-name forms in the US: Ozempic (subcutaneous injection for type 2 diabetes), Rybelsus (oral tablet for type 2 diabetes), and Wegovy (subcutaneous injection for chronic weight management in adults and adolescents 12 years and older with obesity). Any clinician with prescribing authority in your state, including physicians, nurse practitioners, and physician assistants, can prescribe semaglutide if it is medically appropriate for you. Check your state’s scope-of-practice rules if you plan to use a telehealth service that operates across state lines.
Where to Get Brand-Name Semaglutide
Brand-name semaglutide is dispensed through standard pharmacy channels. The most common access points include:
- Retail pharmacies such as CVS, Walgreens, Walmart, Costco, and independent pharmacies fill semaglutide prescriptions when in stock and when your insurance covers the medication.
- Mail-order pharmacies such as Express Scripts, OptumRx, and Caremark deliver 90-day supplies for many commercial and Medicare plans.
- Specialty pharmacies handle Wegovy for some employer plans that route weight-management drugs through a separate channel with prior authorization.
- NovoCare and the manufacturer savings card from Novo Nordisk can lower out-of-pocket costs for commercially insured patients. Eligibility excludes federal program beneficiaries.
If your plan denies coverage, ask your prescriber to submit a prior authorization or appeal letter that documents the diagnosis and prior therapies tried. The Treatment options for prediabetes are summarized in our treatment hub.
Telehealth Options for Semaglutide
Several telehealth platforms now offer end-to-end semaglutide care, including a clinical visit, prescription, lab review when needed, and shipment from a partnering pharmacy. Common options include:
| Platform | Typical Offering | Notes |
|---|---|---|
| Hims and Hers | Brand-name Wegovy or Ozempic via partner pharmacy; previously offered compounded | Limited compounded supply per FDA enforcement; check current status. |
| Ro | Brand-name Wegovy or Ozempic via Ro Pharmacy or insurance | Includes ongoing clinician check-ins. |
| Sequence (now WeightWatchers Clinic) | Brand-name GLP-1 prescriptions; insurance billing supported | Coaching and metabolic labs included. |
| Noom Med | Brand-name semaglutide or tirzepatide where eligible | Behavioral program plus medication management. |
| Calibrate, Found, Form Health | Brand-name GLP-1 with metabolic labs and coaching | Cash-pay or insurance, depending on the program. |
Insurance, Cash Pay, and Patient Assistance
Whether semaglutide is covered, and at what cost, depends on the indication and your plan design. For Ozempic, most commercial and Medicare Part D plans cover the medication for a documented type 2 diabetes diagnosis, often after prior authorization. For Wegovy, employer-sponsored plans increasingly cover the drug, but Medicare historically excluded weight-management medications, although recent rule changes for cardiovascular indications expanded coverage in some cases. If you pay out of pocket, the list price for a 28-day supply can exceed $1,300, with manufacturer savings cards reducing the price for eligible commercial patients. For lower-cost patient assistance, ask your prescriber about Novo Nordisk’s Patient Assistance Program for uninsured and low-income patients who meet the income criteria.
What About Compounded Semaglutide?
During the 2022 to 2024 FDA shortage, compounding pharmacies could legally produce semaglutide preparations under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. The FDA declared the semaglutide shortage resolved in 2025, and large-scale outsourcing facilities (503B) are generally no longer permitted to make copies of an approved drug that is no longer in shortage. Patient-specific 503A compounding remains permitted in narrow cases, such as a documented allergy to an inactive ingredient in the brand product, but routine compounded weight-loss programs are now in legal jeopardy. Per the FDA’s semaglutide guidance page, compounded products are not FDA-approved, and the agency has warned against products containing semaglutide salts that have not been evaluated for safety or efficacy.
How to Verify a Pharmacy or Telehealth Provider
Before you hand over payment information, confirm three things. First, the pharmacy is licensed in your state, which you can check through your state board of pharmacy or the National Association of Boards of Pharmacy (NABP) Verified Pharmacy Program. Second, the prescriber is licensed and has performed a synchronous or asynchronous evaluation that meets your state’s telehealth standards. Third, the medication arrives in a tamper-evident package with the manufacturer’s lot number, expiration date, and instructions for use. If anything looks off, do not inject the product and contact the pharmacy.
Side Effects to Discuss With Your Prescriber
Regardless of where you obtain semaglutide, the safety profile is the same. Common adverse reactions per the Ozempic prescribing information include nausea, diarrhea, vomiting, constipation, abdominal pain, and decreased appetite. Less common but serious risks include pancreatitis, gallbladder disease, kidney injury from dehydration, and a boxed warning regarding thyroid C-cell tumors observed in rodent studies. Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. If you have prediabetes and are exploring weight-management therapy, see our overview of A1C levels for context on glucose monitoring.
The Bottom Line
The legitimate path to semaglutide in the US is straightforward: a clinician evaluates you, writes a prescription for Ozempic, Wegovy, or Rybelsus, and a licensed pharmacy fills it. Telehealth has expanded access and convenience, but it does not change the prescription requirement. Compounded options that were widely available during the shortage are no longer broadly legal, so verify any non-brand source with caution and rely on your prescriber to monitor side effects, dose titration, and long-term outcomes.
Medical disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication or treatment plan.
